BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer ; volume:13 ; number:1 ; day:5 ; month:11 ; year:2013 ; pages:1-11 ; date:12.2013
BMC cancer ; 13, Heft 1 (5.11.2013), 1-11, 12.2013
- Creator
-
Jacot, William
- Contributor
-
Thèzenas, Simon
Senal, Romain
Viglianti, Cathy
Laberenne, Anne-Claire
Lopez-Crapez, Evelyne
Bibeau, Frederic
Bleuse, Jean-Pierre
Romieu, Gilles
Lamy, Pierre-Jean
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-13-523
- URN
-
urn:nbn:de:1111-2016030411411
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jacot, William
- Thèzenas, Simon
- Senal, Romain
- Viglianti, Cathy
- Laberenne, Anne-Claire
- Lopez-Crapez, Evelyne
- Bibeau, Frederic
- Bleuse, Jean-Pierre
- Romieu, Gilles
- Lamy, Pierre-Jean
- SpringerLink (Online service)
Other Objects (12)
Loss of BRCA1 promoter hypermethylation in recurrent high-grade ovarian cancer
Identifying the BRCA1 c.-107A > T variant in Dutch patients with a tumor BRCA1 promoter hypermethylation
Frequent RASSF1A gene promoter hypermethylation in breast cancer
Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of “Second Hit” in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma
Immune pressures drive the promoter hypermethylation of neoantigen genes
Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma
SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation
TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
CHD5 is down-regulated through promoter hypermethylation in gastric cancer
TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas
Pervasive promoter hypermethylation of silenced TERT alleles in human cancers
PER3 promoter hypermethylation correlates to the progression of pan-cancer
Loss of BRCA1 promoter hypermethylation in recurrent high-grade ovarian cancer
Identifying the BRCA1 c.-107A > T variant in Dutch patients with a tumor BRCA1 promoter hypermethylation
Frequent RASSF1A gene promoter hypermethylation in breast cancer
Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of “Second Hit” in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma
Immune pressures drive the promoter hypermethylation of neoantigen genes
Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma
SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation
TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
CHD5 is down-regulated through promoter hypermethylation in gastric cancer
TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas
Pervasive promoter hypermethylation of silenced TERT alleles in human cancers
PER3 promoter hypermethylation correlates to the progression of pan-cancer
Loss of BRCA1 promoter hypermethylation in recurrent high-grade ovarian cancer
Identifying the BRCA1 c.-107A > T variant in Dutch patients with a tumor BRCA1 promoter hypermethylation
Frequent RASSF1A gene promoter hypermethylation in breast cancer
Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of “Second Hit” in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma
Immune pressures drive the promoter hypermethylation of neoantigen genes
Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma
SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation
TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
CHD5 is down-regulated through promoter hypermethylation in gastric cancer
TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas
Pervasive promoter hypermethylation of silenced TERT alleles in human cancers